Encode, founded in 1994 with a focus on microbiology, is dedicated to the in vitro diagnostic (IVD) field, covering R&D, production, and sales of human disease diagnostic products. The company has expanded into immunoassays, chemiluminescence, and molecular diagnostics. Its most prominent product lines span women's reproductive health, respiratory, gastrointestinal, and Mycobacterium tuberculosis, featuring integrated solutions across multiple technology platforms.
Encode seeks to unlock greater possibilities for all lives, delivering better products, services, and solutions to patients and healthcare providers.
